News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
717,543 Results
Type
Article (42629)
Company Profile (268)
Press Release (674646)
Multimedia
Podcasts (50)
Webinars (14)
Section
Business (208920)
Career Advice (2237)
Deals (36082)
Drug Delivery (101)
Drug Development (81891)
Employer Resources (175)
FDA (16598)
Job Trends (15304)
News (352377)
Policy (33219)
Tag
Academia (2705)
Accelerated approval (5)
Adcomms (21)
Allergies (89)
Alliances (51209)
ALS (90)
Alzheimer's disease (1402)
Antibody-drug conjugate (ADC) (127)
Approvals (16594)
Artificial intelligence (271)
Autoimmune disease (21)
Automation (16)
Bankruptcy (366)
Best Places to Work (12006)
BIOSECURE Act (20)
Biosimilars (106)
Biotechnology (186)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (284)
Cancer (2281)
Cardiovascular disease (179)
Career advice (1869)
Career pathing (30)
CAR-T (153)
Cell therapy (430)
Cervical cancer (19)
Clinical research (66523)
Collaboration (858)
Company closure (1)
Compensation (534)
Complete response letters (23)
COVID-19 (2689)
CRISPR (42)
C-suite (245)
Cystic fibrosis (101)
Data (2216)
Decentralized trials (2)
Denatured (19)
Depression (45)
Diabetes (274)
Diagnostics (6602)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (121)
Drug pricing (105)
Drug shortages (26)
Duchenne muscular dystrophy (94)
Earnings (87683)
Editorial (38)
Employer branding (22)
Employer resources (149)
Events (115180)
Executive appointments (746)
FDA (17884)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (777)
Gene editing (108)
Generative AI (20)
Gene therapy (315)
GLP-1 (734)
Government (4531)
Grass and pollen (5)
Guidances (67)
Healthcare (19476)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (118)
Indications (30)
Infectious disease (2835)
Inflammatory bowel disease (139)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (373)
IPO (16738)
IRA (40)
Job creations (3719)
Job search strategy (1576)
Kidney cancer (10)
Labor market (38)
Layoffs (480)
Leadership (18)
Legal (8050)
Liver cancer (76)
Lung cancer (324)
Lymphoma (155)
Machine learning (7)
Management (58)
Manufacturing (312)
MASH (67)
Medical device (13948)
Medtech (13953)
Mergers & acquisitions (19900)
Metabolic disorders (701)
Multiple sclerosis (82)
NASH (16)
Neurodegenerative disease (90)
Neuropsychiatric disorders (27)
Neuroscience (1951)
NextGen: Class of 2025 (6826)
Non-profit (4629)
Now hiring (39)
Obesity (374)
Opinion (216)
Ovarian cancer (75)
Pain (89)
Pancreatic cancer (84)
Parkinson's disease (151)
Partnered (21)
Patents (236)
Patient recruitment (112)
Peanut (48)
People (58694)
Pharmaceutical (64)
Pharmacy benefit managers (18)
Phase I (20736)
Phase II (29283)
Phase III (21835)
Pipeline (1211)
Policy (142)
Postmarket research (2598)
Preclinical (8864)
Press Release (68)
Prostate cancer (107)
Psychedelics (32)
Radiopharmaceuticals (251)
Rare diseases (385)
Real estate (6114)
Recruiting (66)
Regulatory (22752)
Reports (46)
Research institute (2452)
Resumes & cover letters (375)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (71)
Series A (137)
Series B (89)
Service/supplier (16)
Sickle cell disease (54)
Special edition (14)
Spinal muscular atrophy (152)
Sponsored (32)
Startups (3682)
State (2)
Stomach cancer (13)
Supply chain (72)
Tariffs (41)
The Weekly (29)
Vaccines (720)
Venture capitalists (44)
Weight loss (245)
Women's health (35)
Worklife (17)
Date
Last 7 days (912)
Last 30 days (2532)
Last 365 days (33193)
2025 (10959)
2024 (35875)
2023 (40801)
2022 (52029)
2021 (56709)
2020 (55479)
2019 (48318)
2018 (36460)
2017 (33053)
2016 (32601)
2015 (38659)
2014 (32284)
2013 (27263)
2012 (29506)
2011 (30126)
2010 (28051)
Location
Africa (765)
Alabama (53)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (39123)
Australia (6432)
California (6199)
Canada (2032)
China (531)
Colorado (272)
Connecticut (278)
Delaware (151)
Europe (85797)
Florida (921)
Georgia (218)
Idaho (62)
Illinois (561)
India (26)
Indiana (317)
Iowa (11)
Japan (162)
Kansas (105)
Kentucky (26)
Louisiana (11)
Maine (62)
Maryland (906)
Massachusetts (4640)
Michigan (240)
Minnesota (403)
Mississippi (2)
Missouri (89)
Montana (27)
Nebraska (25)
Nevada (64)
New Hampshire (64)
New Jersey (1755)
New Mexico (29)
New York (1771)
North Carolina (1008)
North Dakota (8)
Northern California (2702)
Ohio (212)
Oklahoma (15)
Oregon (35)
Pennsylvania (1389)
Puerto Rico (12)
Rhode Island (35)
South America (1162)
South Carolina (24)
South Dakota (1)
Southern California (2330)
Tennessee (102)
Texas (919)
United States (23544)
Utah (186)
Virginia (151)
Washington D.C. (65)
Washington State (560)
West Virginia (3)
Wisconsin (64)
717,543 Results for "ablative solutions inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Neuroscience
GSK Dives Deeper Into Neuro With $2.5B+ ABL Bio Pact
GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.
April 7, 2025
·
2 min read
·
Tristan Manalac
Press Releases
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America
May 1, 2025
·
7 min read
Genetown
Ablative Solutions, Inc. Announces Primary Endpoint Met in the TARGET BP I Pivotal Trial of the Peregrine System™ Kit for Patients with Uncontrolled Hypertension
Ablative Solutions, Inc., today announced that the TARGET BP I Pivotal Trial evaluating alcohol-mediated renal denervation with the Peregrine System ™ Kit met its primary endpoint, showing a statistically significant difference in 24-hour Ambulatory Blood Pressure between treatment and sham procedure at 3 months.
December 19, 2023
·
2 min read
Press Releases
Alimentiv and Dova Health Intelligence (Previously Satisfai Health Inc.) Launch an AI Solution for Scoring of Ulcerative Colitis (UC) at DDW 2025 in San Diego
May 1, 2025
·
3 min read
Press Releases
Better Choice Company Completes Name Change to SRx Health Solutions Inc. and Begins Trading Under the Ticker Symbol ‘SRXH’ Today, Wednesday, April 30, 2025
April 30, 2025
·
2 min read
Press Releases
Oragenics, Inc. Announces Partnership with BRAINBox Solutions to Revolutionize Concussion Diagnosis and Treatment
February 11, 2025
·
5 min read
Press Releases
Glenmark Therapeutics Inc., USA launches Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC)
March 10, 2025
·
2 min read
Press Releases
ABL Bio Announces Grabody-B Brain Delivery Platform License Agreement with GSK to Develop Novel Medicines for Neurodegenerative Diseases
April 7, 2025
·
4 min read
Genetown
Ablative Solutions, Inc. Announces Enrollment Completion of TARGET BP I Study for Patients with Uncontrolled Hypertension
Ablative Solutions, Inc., a company pioneering new approaches to the treatment of hypertension, today announced the completion of patient enrollment in the TARGET BP I Pivotal Study evaluating alcohol-mediated renal denervation with the Peregrine System.
April 12, 2023
·
2 min read
Press Releases
RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution
March 11, 2025
·
7 min read
1 of 71,755
Next
